Trials / Conditions / Neoplasms, Head and Neck

Neoplasms, Head and Neck

19 registered clinical trials studyying Neoplasms, Head and Neck — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinom NCT06790966	PDS Biotechnology Corp.	Phase 3
Recruiting	A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected NCT06256588	GlaxoSmithKline	Phase 3
Active Not Recruiting	A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positi NCT06062420	GlaxoSmithKline	Phase 2
Completed	Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC NCT04260126	PDS Biotechnology Corp.	Phase 2
Terminated	Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Re NCT04428333	GlaxoSmithKline	Phase 3
Terminated	Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Me NCT04128696	GlaxoSmithKline	Phase 3
Unknown	Head and Neck Cancer in Children: A Retrospective Study NCT02557048	Assiut University	—
Completed	Manual Therapy and Use of the Dynasplint for Trismus in Patients With Head and Neck Cancer NCT03178110	University of Alberta	N/A
Completed	Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcino NCT02573493	Washington University School of Medicine	Phase 2
Completed	Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma NCT02296684	Washington University School of Medicine	Phase 2
Terminated	Safety Study of SEA-CD40 in Cancer Patients NCT02376699	Seagen Inc.	Phase 1
Completed	Change in Symptom Clusters in HNC Patients NCT03356093	Taipei Medical University	—
Terminated	Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer NCT01370876	Nang Kuang Pharmaceutical Co., Ltd.	Phase 2
Completed	Normalcy of Food Intake in Head and Neck Cancer Patients NCT01110980	Radboud University Medical Center	N/A
Completed	Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of NCT01116336	Emory University	Phase 1
Completed	Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer NCT00798655	Robert Ferris	Phase 2
Completed	Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck NCT00725764	GlaxoSmithKline	Phase 2
Completed	Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery NCT00424255	GlaxoSmithKline	Phase 3
Completed	Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head A NCT00387127	GlaxoSmithKline	Phase 2